Acute Graft Versus Host Disease - 162 Studies Found
| Completed |
: Extracorporeal Photopheresis in Children and Young Adults With Refractory Acute Graft Versus Host Disease : Graft Versus Host Disease : 2008-12-18 : Procedure: ECP (performed on Themos UVAR-XTS or external UVA irradiator after cell collection by apheresis) |
| Terminated |
: Phase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT) : Glucocorticosteroid Refractory Acute GVHD : 2012-12-13 : Drug: Toclizumab 8 mg/kg IV, once every 1-2 weeks. The maximum dose per infusion should not exceed 800 m |
| Completed |
: GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host Disease : Graft vs Host Disease : 2005-09-27 : Drug: Infliximab |
| Completed |
: A Study Using Tacrolimus, Sirolimus and Bortezomib as Acute Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation :
|
| Completed |
: Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients With Acute Graft Versus Host Disease (GVHD) : Graft-Versus-Host Disease : 2010-04-16 : Drug: Panobinostat (LBH589) Phase I Initial Treatment Plan |
| Completed |
: A Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH1) : Graft-versus-host Disease : 2016-11-01 :
|
| Completed |
: Analysis of Biomarkers for Acute Graft-versus-Host Disease (GVHD) : Blood Stem Cell Transplant Failure : 2012-03-29 |
| Completed |
: Topical Vitamin D in Acute Graft Versus Host Disease of the Skin : Graft Vs Host Disease : 2017-03-23 : Dietary Supplement: Calcipotriene Topical vitamin D cream will be applied to affected areas of the skin. |
| Completed |
: Decidual Stromal Cells as Treatment for Acute Graft Versus Host Disease, a Phase 1-2 Study : Graft vs Host Disease : 2014-06-17 :
|
| Completed |
: Phase II Trial of Pentostatin in Steroid Refractory Acute Graft Versus Host Disease : Graft-Versus-Host Disease : 2005-09-12 : Drug: Pentostatin Pentostatin is given at a dose of 1.5 mg/m2/day IV x 3 consecutive days. Each IV infus |